Loading...
OTC Markets
Totals
Securities
11,065
Dollar Vol
$0.0
Share Vol
0
Trades
0

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

CRLBF
Cresco Labs Inc.

Ordinary Shares

0.50

-0.01

-1.96%

No Inside Bid / Offer

Delayed (15 Min) Trade Data: 12:00am 07/03/2025
OTC Disclosure & News Service

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the first quarter ended March 31st, 2024 on Wednesday, May 15th, 2024 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs First Quarter 2024 Earnings Conference Call
Date: Wednesday, May 15th, 2024
Time: 8:30 am EST
Webcast: LINK
Dial-in: 1-833-470-1428 (US Toll Free), 1-404-975-4839 (US Local)
Access Code: 897519

Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.

About Cresco Labs Inc.

Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs’ journey by visiting www.crescolabs.com or following the Company on Facebook, X or LinkedIn.

OTCQX Best Market Logo
Joined OTCQX 03/2019
The Company Profile data was verified by the issuer within the previous 6 months.
This security is not a Penny Stock as defined in SEC Rule 240.3a51-1.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Daily Advancers
    Subscribe to Our Newsletter
    Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.